USANA Health Sciences, Inc.
USNA
$20.03
$0.231.16%
NYSE
| 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/28/2024 | 09/28/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.52M | 9.66M | 9.40M | 4.45M | 10.61M |
| Total Depreciation and Amortization | 9.57M | 9.60M | 10.25M | 5.88M | 5.56M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.92M | -2.57M | 5.33M | 948.00K | 4.77M |
| Change in Net Operating Assets | -10.93M | -4.48M | -9.50M | -5.50M | 8.59M |
| Cash from Operations | -1.96M | 12.22M | 15.48M | 5.79M | 29.53M |
| Capital Expenditure | -3.20M | -5.03M | -2.80M | -1.80M | -2.40M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 61.00K |
| Cash Acquisitions | -- | -- | -- | -203.34M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 865.00K | -1.07M | 0.00 | 0.00 |
| Cash from Investing | -3.20M | -4.16M | -3.88M | -205.14M | -2.34M |
| Total Debt Issued | 0.00 | 1.60M | -- | 23.00M | -2.00K |
| Total Debt Repaid | 0.00 | -24.60M | -- | 6.00K | 3.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -100.00K | -15.23M | -14.47M | -74.00K | -79.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -879.00K | -379.00K | -- | -- | -- |
| Cash from Financing | -979.00K | -38.61M | -14.47M | 22.93M | -78.00K |
| Foreign Exchange rate Adjustments | 165.00K | 2.31M | 719.00K | -6.81M | 5.45M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.97M | -28.24M | -2.14M | -183.23M | 32.57M |